This is a report from SAMHSA for a wide range of stakeholders (healthcare professionals, policymakers, patients, and families) that gives an overview of the three FDA-approved medications used to treat opioid use disorder (OUD) as well as other strategies and services needed to support recovery for people with OUD. Resources are provided at the end of this document. An executive summary of the report can be found here.